Sarda Proteins Ltd
Fundamental Score
Sarda Proteins Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of SRDAPRT across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Robust Profit Growth (263.64%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (2971.43%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (34.97% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Conservative Debt Levels (D/E: 0.07)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
10 factors identified
Below-Average Return on Equity (0.42%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.84%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (-0.07%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Weak Earnings Growth (-19.73% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (-19.73% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
Negative Free Cash Flow (₹-0.59 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Sarda Proteins Ltd
About SRDAPRT
Business Overview
Sarda Proteins Ltd trades edible oils and agri commodities in India. The company also trades oil seeds, grains, and mustard oil, as well as renewable energy solar cells. In addition, it provides manpower services. The company was incorporated in 1991 and is based in Alwar, India.
Company Details
Key Leadership
SRDAPRT Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Sarda Proteins Ltd (SRDAPRT)?
As of 19 Jan 2026, 10:12 am IST, Sarda Proteins Ltd (SRDAPRT) is currently trading at ₹70.41. The stock has a market capitalization of ₹13.84 (Cr).
Is SRDAPRT share price Overvalued or Undervalued?
SRDAPRT is currently trading at a P/E ratio of 0.00x, compared to the industry average of 26.18x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Sarda Proteins Ltd share price?
Key factors influencing SRDAPRT's price include its quarterly earnings growth (Sales Growth: 2971.43%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Sarda Proteins Ltd a good stock for long-term investment?
Sarda Proteins Ltd shows a 5-year Profit Growth of -19.73% and an ROE of 0.42%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.07 before investing.
How does Sarda Proteins Ltd compare with its industry peers?
Sarda Proteins Ltd competes with major peers in the Edible Oil. Investors should compare SRDAPRT's P/E of 0.00x and ROE of 0.42% against the industry averages to determine its competitive standing.
What is the P/E ratio of SRDAPRT and what does it mean?
SRDAPRT has a P/E ratio of N/Ax compared to the industry average of 26.18x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is SRDAPRT performing according to Bull Run's analysis?
SRDAPRT has a Bull Run fundamental score of 28.4/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does SRDAPRT belong to?
SRDAPRT operates in the Edible Oil industry. This classification helps understand the competitive landscape and sector-specific trends affecting Sarda Proteins Ltd.
What is Return on Equity (ROE) and why is it important for SRDAPRT?
SRDAPRT has an ROE of 0.42%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Sarda Proteins Ltd generates profits from shareholders' equity.
How is SRDAPRT's debt-to-equity ratio and what does it indicate?
SRDAPRT has a debt-to-equity ratio of 0.07, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is SRDAPRT's dividend yield and is it a good dividend stock?
SRDAPRT offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has SRDAPRT grown over the past 5 years?
SRDAPRT has achieved 5-year growth rates of: Sales Growth 34.97%, Profit Growth -19.73%, and EPS Growth -19.73%.
What is the promoter holding in SRDAPRT and why does it matter?
Promoters hold 0.00% of SRDAPRT shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is SRDAPRT's market capitalization category?
SRDAPRT has a market capitalization of ₹14 crores, placing it in the Small-cap category.
How volatile is SRDAPRT stock?
SRDAPRT has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for SRDAPRT?
SRDAPRT has a 52-week high of ₹N/A and low of ₹N/A.
What is SRDAPRT's operating profit margin trend?
SRDAPRT has a 5-year average Operating Profit Margin (OPM) of -0.07%, indicating the company's operational efficiency.
How is SRDAPRT's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 2971.43% and YoY Profit Growth of 263.64%.
What is the institutional holding pattern in SRDAPRT?
SRDAPRT has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.